Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-12-08
2009-12-08
Kelly, Robert M (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093100, C435S320100, C435S006120, C536S023100
Reexamination Certificate
active
07629326
ABSTRACT:
Methods of modifying, repairing, attenuating and inactivating a gene or other chromosomal DNA in a cell are disclosed. Also disclosed are methods of treating or prophylaxis of a genetic disease in an individual in need thereof. Further disclosed are chimeric restriction endonucleases.
REFERENCES:
patent: 5436150 (1995-07-01), Chandrasegaran
patent: 5674499 (1997-10-01), Willemse et al.
patent: 5830729 (1998-11-01), Jaisser et al.
patent: 5962327 (1999-10-01), Dujon et al.
patent: 6238924 (2001-05-01), Dujon et al.
patent: 7285538 (2007-10-01), Choulika et al.
patent: 2002/0110898 (2002-08-01), Choulika et al.
patent: 2007/0141038 (2007-06-01), Choulika et al.
patent: WO 96/14408 (1996-05-01), None
patent: WO 00/46385 (2000-08-01), None
Alwin et al. (2005) Mol. Ther. 12:610-617.
Bibikova et al. (2001) Mol. Cell. Biol. 21:289-297.
Rubanyi (2001) Mol. Aspects Med. 22:113-142.
Eck et al. (1996) Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Edition, Chapter 5, McGraw-Hill, NY.
Paques et al. (2007) Curr. Gene Ther. 7:49-66.
Cohen-Tannoudji, M. et al., “I-SceI-Induced Gene Replacement at a Natural Locus in Embryonic Stem Cells,”Molecular and Cellular Biology, 18(3):1444-1448 (1998).
Choulika, A. et al., “Induction of Homologous Recombination in Mammalian Chromosomes by Using the I-SceI System of Saccharomyces cerevisiae,”Molecular and Cellular Biology, 15(4):1968-1973 (1995).
Choulika, A. et al., “The Yeast I-SceI Meganuclease Induces Site-Directed Chromosomal Recombination in Mammalian Cells,” C.R. Acad. Sci. Paris, Life Sciences,Genetics, 317:1013-1019 (1994).
Smith, J. et al., “A Detailed Study of the Substrate Specificity of a Chimeric Restriction Enzyme,”Nucleic Acids Res., 27(2):674-681 (1999).
Nahon, E. and Raveh, D., “Targeting a Truncated Ho-Endonuclease of Yeast to Novel DNA Sites with Foreign Zinc Fingers,”Nucleic Acids Res., 26(5):1233-1239 (1998).
Kim, Y.G. et al., “Hybrid Restriction Enzymes: Zinc Finger Fusions to Fok I Cleavage Domain,”Proc. Natl. Acad. Sci. USA, 93(3):1156-1160 (1996).
Verma, I.M. et al., “Gene Therapy-promises, problems and prospects,”Nature, 389:239-242 (1997).
Marshall, E., “Gene Therapy's Growing Pains,”Science, 269:1050, 1052-1055 (1995).
Ross, G. et al., “Gene Therapy in the United States: A Five-Year Status Report,”Human Gene Therapy, 7 :1781-1790 (1996).
Orkin, “Report and Recommendations of the Panel to Access the NIH Investment in Research in Gene Therapy,” NIH Press, pp. 1-40 (Dec. 7, 1995).
“There are Common Motifs in Many Sequence-Specific DNA-Binding Proteins,” inMolecular Biology of the Cell, 2nded., Alberts, B., et al., (edu.)(NY: Garland Publishing, Inc.) Chap. 9, 490 (1989).
Promega, Revolutions in Science, 1993/94 Catalog, p. 20.
Anderson, W.F., “Human gene therapy,”Nature, 392 (Suppl):25-30 (1998).
Nishikawa, M. and Huang, L., “Nonviral Vectors in the New Millenium: Delivery Barriers in Gene Transfer,”Human Gene Therapy, 12:861-870 (2001).
Balicki, D., and Beutler, E., “Gene Therapy of Human Disease,”Medicine, 81(1):69-86 (2002).
Rozenberg, Y., et al., “Alternative gene delivery,”S.T.P. Pharma Sciences, 11(1):21-30 (2001).
Plessis, A., et al., “Site-Specific Recombination Determined by I-Scel, a Mitochondrial Group I Intron-Encoded Endonuclease Expressed in the Yeast Nucleus,”Genetics 130:451-460 (Mar. 1992).
Rouet, P., et al., “Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells,”Proc. Natl. Acad. Sci. USA:91:6064-6068 (Jun. 1994).
Kim, Y-G., and Chandrasegaran, S., “Chimeric Restriction Endonuclease,”Proc. Natl. Acad. Sci. USA, 91: 883-887 (1994).
Choulika Andre
Mulligan Richard C.
Children's Medical Center Corporation
Hamilton Brook Smith & Reynolds P.C.
Institut Pasteur
Kelly Robert M
LandOfFree
Chromosomal modification involving the induction of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chromosomal modification involving the induction of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromosomal modification involving the induction of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4065825